| Authors: |
Burq M; Verily Life Sciences, South San Francisco, CA, USA. mburq@verily.com., Rainaldi E; Verily Life Sciences, South San Francisco, CA, USA., Ho KC; Verily Life Sciences, South San Francisco, CA, USA., Chen C; Verily Life Sciences, South San Francisco, CA, USA., Bloem BR; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands., Evers LJW; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands.; Radboud University, Institute for Computing and Information Sciences, Nijmegen, the Netherlands., Helmich RC; Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, the Netherlands., Myers L; Verily Life Sciences, South San Francisco, CA, USA., Marks WJ Jr; Verily Life Sciences, South San Francisco, CA, USA., Kapur R; Verily Life Sciences, South San Francisco, CA, USA. |
